FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078390 [Registered on: 20/12/2024] Trial Registered Prospectively
Last Modified On: 19/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Understanding Diabetes Care and Medication in Kundapura 
Scientific Title of Study   A study on medications, knowledge and adherence among the known type 2 Diabetes Mellitus patients in Kundapura, Udupi district 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Not Applicable  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Inchara A Hegde 
Designation  Primary Student Researcher 
Affiliation  Prasanna School of Public Health,MAHE 
Address  Department of Global Public Health Policy and Governance, Prasanna School of Public Health,MAHE,Manipal,Karnataka, India

Udupi
KARNATAKA
576104
India 
Phone  9483211056  
Fax    
Email  inchara.psphmpl2023@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kumar Sumit 
Designation  Associate Professor 
Affiliation  Prasanna School of Public Health,MAHE 
Address  Room number 53,Department of Global Public Health Policy and Governance, Prasanna School of Public Health, MAHE, Manipal, Karnataka, India

Udupi
KARNATAKA
576104
India 
Phone  8867620088  
Fax    
Email  kumar.sumit@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Kumar Sumit 
Designation  Associate Professor 
Affiliation  Prasanna School of Public Health,MAHE 
Address  Room number 53,Department of Global Public Health Policy and Governance, Prasanna School of Public Health, MAHE, Manipal, Karnataka, India

Udupi
KARNATAKA
576104
India 
Phone  8867620088  
Fax    
Email  kumar.sumit@manipal.edu  
 
Source of Monetary or Material Support  
Prasanna School Of Public Health,Madhav Nagar,Eshwar Nagar,Manipal,Karnataka,India 576104  
 
Primary Sponsor  
Name  Dr Inchara A Hegde 
Address  Department of Global Public Health Policy and Governance,Prasanna School Of Public Health,MAHE,Manipal,Karnataka 576104 
Type of Sponsor  Other [Self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Inchara A Hegde  Prasanna School of Public Health  Department of Global Public Health Policy and Governance, Prasanna School of Public Health,MAHE,Manipal,Karnataka, India
Udupi
KARNATAKA 
9483211056

inchara.psphmpl2023@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee-2(Student Research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E118||Type 2 diabetes mellitus with unspecified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Both Inpatient and Outpatient department patients at Secondary care hospital Kundapura.
Both male and female with known type 2 diabetes Mellitus patients aged 45 years old and above.
Patients who were diagnosed with type 2 diabetes mellitus for more than a year before the study 
 
ExclusionCriteria 
Details  Patients with known type I diabetes mellitus.
Patients with gestational diabetes.
Patients who are Terminally ill or Seriously ill.
Patients with cognitive impairment or inability to provide informed consent. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the Medications knowledge among known Type 2 Diabetes Mellitus patients in Kundapura Udupi district  25 December 2024 to 1 March 2025 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the Factors influencing Adherence of medication  30 March 2025 to 30 June 2025 
 
Target Sample Size   Total Sample Size="207"
Sample Size from India="207" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A study on medication knowledge and adherence among the known type 2 diabetes Mellitus patients in Kundapura aims to assess the impact of medication knowledge and adherence among diabetic patients, as this is a significant global health issue that has emerged due to rapid cultural, economic, and social transformations. Factors contributing to its rise include ageing populations, unplanned urban growth, dietary shifts characterized by higher intake of processed foods and sugary drinks, and obesity. decreased physical activity, and the adoption of unhealthy lifestyles. Previous studies have demonstrated that nonadherence to antidiabetic medications can result in poor glycemic control and can consequently lead to complications associated with disease progression, hospitalization, and premature disability. and mortality. It is important to educate the diabetic population about antidiabetic medication to prevent future complications of type 2 diabetes Mellitus. 
Close